|Videos|May 27, 2023
Discussing Rapid Accurate mRNA Potency Assay Possibilities with Sean Hart
Author(s)Chris Spivey
Sean Hart, CEO and SCO of LumaCyte, discusses rapid accurate mRNA potency assay possibilities.
Advertisement
Chris Spivey, editorial director, speaks with Sean Hart, CEO and SCO of LumaCyte, on the topic of rapid accurate mRNA potency assay possibilities.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
What to Know About Regulations in June 2026
2
BioPhorum Unites 20 Organizations to Modernize Small Molecule Production
3
FDA Grants First-in-Class Approval for Treg Cell Therapy in Blood Cancer Transplant Patients
4
Regulatory Actions for June 2026
5